To determine whether T cells present in the tumor during early development, which are predominantly TRM-like cells, contribute to immunoediting, we depleted CD8+ T cells using an anti-CD8α antibody beginning at the first signs of pigmentation and continuing every five days until the end of the experiment (Figure S8B). The gene discussed is CD8A; the disease is neoplasm.